Strategic Direction

  • June 24, 2024

    George Mason University has joined the Alliance of Art Research Universities (a2ru) as an institutional member. This action uniquely positions George Mason among other R1 institutions to support an emerging research culture in the arts.

  • June 14, 2024

    George Mason University Korea kicked off its 10th anniversary celebrations with a lively reception that brought together Mason Korea students, faculty, and staff, current and past leaders, visitors from George Mason's Fairfax Campus; and members of the Mason Korea advisory board.

  • March 28, 2024

    On Tuesday, March 19, 2024, Delegate Kathy Tran presented Mason Community Arts Academy Executive Director Mary Lechter with House Resolution 804, in honor of Acting for Young People’s (AFYP) 25th anniversary in 2022. AFYP is a partner program within Mason Community Arts Academy (MCAA) the community arts education division of Mason’s College of Visual and Performing Arts.

  • October 10, 2023

    ARTS by George! returned on Saturday, September 30, 2023, hosted by the College of Visual and Performing Arts (CVPA) at George Mason University. The benefit event, which was headlined by GRAMMY and Tony Award winner Renée Elise Goldsberry, raised more than $275,000 for student scholarships in visual arts, dance, music, theater, game design, film, arts management, as well as for the Mason Community Arts Academy, Green Machine Ensembles, and the Great Performances at Mason season at the Center for the Arts.

  • September 18, 2023

    Multiple national college rankings released in recent weeks have placed George Mason University among America’s top 50 public universities, top 100 among all public and private institutions, and Virginia’s No. 1 public university for social mobility.

  • December 7, 2022

    George Mason University’s commitment to anti-racism and inclusive excellence is being honored with the 2022 NAACP Arlington Branch President's Award.

  • November 22, 2022

    Mason hosts international symposium on digital therapeutics